Cargando…

Current Options in the Treatment of COVID-19: A Review

Novel Coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and spread rapidly all around the world infecting many people. To date, no specific vaccines and drugs have been developed for this disease. Also, due to the COVID-19 pand...

Descripción completa

Detalles Bibliográficos
Autores principales: Teimury, Azadeh, Mahmoodi Khaledi, Elahe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549493/
https://www.ncbi.nlm.nih.gov/pubmed/33116980
http://dx.doi.org/10.2147/RMHP.S265030
_version_ 1783592804627251200
author Teimury, Azadeh
Mahmoodi Khaledi, Elahe
author_facet Teimury, Azadeh
Mahmoodi Khaledi, Elahe
author_sort Teimury, Azadeh
collection PubMed
description Novel Coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and spread rapidly all around the world infecting many people. To date, no specific vaccines and drugs have been developed for this disease. Also, due to the COVID-19 pandemic and high prevalence of the infected patients, the drugs and the therapies of other past viral epidemics have been used for this disease. Many studies have been performed on the specific treatments to find whether or not they are effective on COVID-19 patients. In this review, we collected information about the most widely used drugs to treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune modulators, and anticoagulants. Some of these compounds and drugs were used directly by inpatients, so researchers have examined others in laboratory conditions. This study considered the pros and cons of using these treatments separately and together and compared their results. By studying this review, we hope to provide useful information for researchers.
format Online
Article
Text
id pubmed-7549493
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75494932020-10-27 Current Options in the Treatment of COVID-19: A Review Teimury, Azadeh Mahmoodi Khaledi, Elahe Risk Manag Healthc Policy Review Novel Coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 in China and spread rapidly all around the world infecting many people. To date, no specific vaccines and drugs have been developed for this disease. Also, due to the COVID-19 pandemic and high prevalence of the infected patients, the drugs and the therapies of other past viral epidemics have been used for this disease. Many studies have been performed on the specific treatments to find whether or not they are effective on COVID-19 patients. In this review, we collected information about the most widely used drugs to treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune modulators, and anticoagulants. Some of these compounds and drugs were used directly by inpatients, so researchers have examined others in laboratory conditions. This study considered the pros and cons of using these treatments separately and together and compared their results. By studying this review, we hope to provide useful information for researchers. Dove 2020-10-08 /pmc/articles/PMC7549493/ /pubmed/33116980 http://dx.doi.org/10.2147/RMHP.S265030 Text en © 2020 Teimury and Mahmoodi Khaledi. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Teimury, Azadeh
Mahmoodi Khaledi, Elahe
Current Options in the Treatment of COVID-19: A Review
title Current Options in the Treatment of COVID-19: A Review
title_full Current Options in the Treatment of COVID-19: A Review
title_fullStr Current Options in the Treatment of COVID-19: A Review
title_full_unstemmed Current Options in the Treatment of COVID-19: A Review
title_short Current Options in the Treatment of COVID-19: A Review
title_sort current options in the treatment of covid-19: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549493/
https://www.ncbi.nlm.nih.gov/pubmed/33116980
http://dx.doi.org/10.2147/RMHP.S265030
work_keys_str_mv AT teimuryazadeh currentoptionsinthetreatmentofcovid19areview
AT mahmoodikhaledielahe currentoptionsinthetreatmentofcovid19areview